Showing results (1-10 of 526) with videos related to
Sort By:
Pageof 53
Journal of Clinical Medicine|January 26, 2024
Chronic Liver Diseases: What is Up?Sharmila Fagoonee, Pietro InvernizziDiseases (Basel, Switzerland)|June 14, 2020
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor AgonistsLudovico Abenavoli, Anna Caterina Procopio, Sharmila Fagoonee, et al.Cells|December 17, 2024
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic StrategiesSharmila Fagoonee, Ralf WeiskirchenJournal of Clinical Medicine|November 2, 2019
Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?Sharmila Fagoonee, Rinaldo PellicanoFrontiers in Cell and Developmental Biology|June 15, 2026
Lipid nanoparticles and extracellular vesicles: emerging cell free therapeutic platforms for hepatobiliary cancersGabriele Saccu, Sharmila FagooneeJournal of Clinical Medicine|August 14, 2020
Promises of Fibroblast Growth Factor Receptor-Directed Therapy in Tailored Cancer TreatmentSharmila Fagoonee, Rinaldo PellicanoInfectious Diseases (London, England)|March 26, 2019
Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short reviewSharmila Fagoonee, Rinaldo PellicanoFrontiers in Molecular Biosciences|June 21, 2024
RNA-binding protein transcripts as potential biomarkers for detecting Primary Sclerosing Cholangitis and for predicting its progression to CholangiocarcinomaUgo Ala, Sharmila FagooneeJPMA. the Journal of the Pakistan Medical Association|November 10, 2018
Comments on Umer Draz et al. (J Pak Med Assoc. 2018; 68: 939-41) Presence of pre-diabetes in Helicobacter pylori positive versus Helicobacter pylori negative patients having dyspepsiaDavide Giuseppe Ribaldone, Sharmila FagooneeMinerva Gastroenterologica E Dietologica|February 15, 2018
Biological properties and pathogenicity factors of Helicobacter pyloriGuzel S Isaeva, Sharmila FagooneePageof 53